Sponsor Pipeline

Mannkind Corporation Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
3
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-23 NCT07344558
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients…		 Trial completed
2026-07-23 NCT07344558
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients…		 Enrollment increased: 24 -> 27 participants
Active Trials by Phase
Phase 2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07679893 Phase 2 Clinical Trial of MNKD-201 (Nintedanib Dry Powder Inhalation) in Patients With… Idiopathic Pulmonary Fibrosis Recruiting
NCT07224321 INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes Type 1 Diabetes Mellitus Recruiting
Phase 1
NCT06532942 A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy… Healthy Volunteers Recruiting
Disease Areas
Type 1 Diabetes (1) Diabetes (1) Idiopathic Pulmonary Fibrosis (1)
Get alerts when Mannkind Corporation's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free